Do microbes with peptides mimicking myelin cause multiple sclerosis if the T cell response to their unique peptides

M D Kaufman1

  • 1MS Center, Carolinas Medical Center, Charlotte, NC 28232, USA.

Insights

Early life T cell responses to pathogens may influence multiple sclerosis risk. Environmental factors like pathogen exposure and latitude impact T cell repertoire development, potentially increasing susceptibility to this autoimmune disease.

Area of Science:

  • Immunology
  • Neuroscience
  • Epidemiology

Background:

  • The pathogenesis of multiple sclerosis (MS) is hypothesized to involve T cell repertoire responses to pathogens.
  • Early life T cell activation, influenced by thymic selection and microbial encounters, shapes immune responses.
  • Reduced pathogen exposure in developed societies may lead to a less diverse T cell repertoire, potentially increasing autoreactivity.

Purpose of the Study:

  • To hypothesize the role of T cell repertoire development in multiple sclerosis pathogenesis.
  • To explore the influence of environmental factors, such as pathogen exposure and geographic location, on immune responses relevant to MS.
  • To investigate potential microbial triggers for myelin-directed T cell responses.

Main Methods:

  • Review of immunologic and epidemiologic observations.
  • Hypothetical modeling of T cell repertoire selection and activation.
  • Analysis of microbial epitope mimicry with myelin antigens.

Main Results:

  • A weakly autoreactive T cell repertoire is established early in life, later supplemented by pathogen-specific responses.
  • Reduced and delayed pathogen exposure may result in a limited memory T cell repertoire, increasing susceptibility to autoimmunity.
  • Pathogens with epitopes mimicking myelin may trigger autoreactive T cell responses, potentially leading to central nervous system injury.

Conclusions:

  • Geographic variations in microbial exposure (equator vs. temperate climates) may influence autoimmunity resistance.
  • Differences in T cell repertoires between populations with varying MS prevalence suggest divergent immune responses.
  • An exuberant innate immune response, potentially linked to microbial load, might confer resistance to MS.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...